Anixa Biosciences Inc — Director's Dealing 2017

Sep 26, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-09-22

Reporting Person: JOHNSON BRUCE F (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	554817	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$2.575	2017-11-30	Common Stock (2400)		Direct
Employee Stock Options (Right to Buy)	$2.575	2022-12-31	Common Stock (12000)		Direct
Employee Stock Options (Right to Buy)	$2.575	2024-01-02	Common Stock (12000)		Direct
Employee Stock Options (Right to Buy)	$2.575	2025-01-02	Common Stock (12000)		Direct
Employee Stock Options (Right to Buy)	$2.92	2026-01-02	Common Stock (12000)		Direct

Footnotes

F1: Right-To-Buy pursuant to the ITUS Corporation 2010 Share Incentive Plan.

F2: Right-To-Buy pursuant to stock options that were not granted under the ITUS Corporation 2010 Share Incentive Plan.